CClinicalTrials.gg
CompletedNCT07806032Updated Sep 8, 2026

Acute Responses to Walking, Stair Climbing, and Functional Circuit Exercise

An interventional study of Walking Protocol and Stair Climbing Protocol in Sedentary Behaviors, sponsored by Malatya Turgut Ozal University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Malatya Turgut Ozal University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

This study evaluated the acute physiological responses to three different exercise modalities in sedentary young men. Participants completed walking, stair climbing, and functional circuit exercise sessions in a randomized crossover design. Each exercise session lasted 20 minutes and was performed at a target intensity of 50% heart rate reserve (±5 beats/min), with at least 72 hours between sessions.

The study compared acute respiratory, metabolic, and neuromotor responses to the three exercise modalities. Pulmonary function was assessed using spirometry, blood lactate concentration was measured using capillary blood samples, and countermovement jump performance was assessed as an indicator of neuromuscular performance. Heart rate was continuously monitored during each exercise session.

02

Conditions studied

  • Sedentary Behaviors

Browse trials for

Keywords

  • Walking
  • Stair Climbing
  • Functional Exercise
  • Heart Rate Reserve
  • Pulmonary Function
  • Blood Lactate
  • Countermovement Jump
  • Sedentary Adults
03

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male sex.
  • Aged 18-30 years.
  • Classified as sedentary/insufficiently active according to the study eligibility criteria.
  • Able to safely complete the exercise protocols and study assessments.
  • Provided voluntary informed consent.

Exclusion criteria

Exclusion Criteria:

  • Current cigarette or electronic cigarette use.
  • Known cardiovascular, respiratory, or metabolic disease.
  • Regular medication use that could affect physiological responses to exercise.
  • Acute infection within the previous 2 weeks.
  • Musculoskeletal conditions that could interfere with safe participation in the exercise protocols.
  • Any condition requiring medical evaluation before exercise participation.
  • Inability to obtain acceptable baseline spirometry measurements according to the study procedures.
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    WP-SP-FCP Sequence

    Participants completed the Walking Protocol first, followed by the Stair Climbing Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.

    Behavioral: Walking Protocol · Behavioral: Stair Climbing Protocol · Behavioral: Functional Circuit Protocol

  • Experimental
    WP-FCP-SP Sequence

    Participants completed the Walking Protocol first, followed by the Functional Circuit Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.

    Behavioral: Walking Protocol · Behavioral: Stair Climbing Protocol · Behavioral: Functional Circuit Protocol

  • Experimental
    SP-WP-FCP Sequence

    Participants completed the Stair Climbing Protocol first, followed by the Walking Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.

    Behavioral: Walking Protocol · Behavioral: Stair Climbing Protocol · Behavioral: Functional Circuit Protocol

  • Experimental
    SP-FCP-WP Sequence

    Participants completed the Stair Climbing Protocol first, followed by the Functional Circuit Protocol and then the Walking Protocol, with at least 72 hours between sessions.

    Behavioral: Walking Protocol · Behavioral: Stair Climbing Protocol · Behavioral: Functional Circuit Protocol

  • Experimental
    FCP-WP-SP Sequence

    Participants completed the Functional Circuit Protocol first, followed by the Walking Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.

    Behavioral: Walking Protocol · Behavioral: Stair Climbing Protocol · Behavioral: Functional Circuit Protocol

  • Experimental
    FCP-SP-WP Sequence

    Participants completed the Functional Circuit Protocol first, followed by the Stair Climbing Protocol and then the Walking Protocol, with at least 72 hours between sessions.

    Behavioral: Walking Protocol · Behavioral: Stair Climbing Protocol · Behavioral: Functional Circuit Protocol

Interventions

  • BehavioralWalking Protocol

    Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate. Heart rate was continuously monitored throughout the exercise session.

    Also known as: WP

  • BehavioralStair Climbing Protocol

    Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate. Heart rate was continuously monitored throughout the exercise session.

    Also known as: SP

  • BehavioralFunctional Circuit Protocol

    Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate. The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface. Heart rate was continuously monitored throughout the exercise session.

    Also known as: FCP

05

What researchers measure

Primary outcomes

  1. Change in Forced Expiratory Volume in One Second (FEV1)

    Forced expiratory volume in one second (FEV1) was measured by spirometry before and 5 minutes after each exercise condition. The primary outcome was the change in FEV1 (ΔFEV1), calculated as post-exercise FEV1 minus pre-exercise FEV1 and expressed in liters (L). Measurements were obtained following standardized spirometry procedures.

    Time frame: Baseline and 5 minutes after each exercise session

Secondary outcomes

  1. Change in Forced Vital Capacity (FVC)

    Forced vital capacity (FVC) was measured by spirometry before and 5 minutes after each exercise condition. The outcome was the change in FVC (ΔFVC), calculated as post-exercise FVC minus pre-exercise FVC and expressed in liters (L).

    Time frame: Baseline and 5 minutes after each exercise session

  2. Change in FEV1/FVC Ratio

    The FEV1/FVC ratio was assessed by spirometry before and 5 minutes after each exercise condition. The outcome was the change in FEV1/FVC ratio (ΔFEV1/FVC), calculated as the post-exercise value minus the pre-exercise value.

    Time frame: Baseline and 5 minutes after each exercise session

  3. Change in Peak Expiratory Flow (PEF)

    Peak expiratory flow (PEF) was measured by spirometry before and 5 minutes after each exercise condition. The outcome was the change in PEF (ΔPEF), calculated as the post-exercise PEF minus the pre-exercise PEF and expressed in liters per second (L/s).

    Time frame: Baseline and 5 minutes after each exercise session

  4. Change in Blood Lactate Concentration

    Capillary blood lactate concentration was measured before exercise and 3 minutes after each exercise condition. The outcome was the change in blood lactate concentration (ΔLactate), calculated as the post-exercise value minus the pre-exercise value and expressed in millimoles per liter (mmol/L).

    Time frame: Baseline and 3 minutes after each exercise session

  5. Change in Countermovement Jump Height (CMJ)

    Countermovement jump (CMJ) height was assessed before and after each exercise condition. The outcome was the change in CMJ height (ΔCMJ), calculated as the post-exercise value minus the pre-exercise value and expressed in centimeters (cm).

    Time frame: Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session

  6. Mean Heart Rate During Exercise

    Heart rate was continuously monitored throughout each exercise condition. Mean heart rate was calculated across the exercise period and expressed in beats per minute (bpm).

    Time frame: During each 20-minute exercise session

  7. Maximum Heart Rate During Exercise

    Heart rate was continuously monitored throughout each exercise condition. Maximum heart rate was defined as the highest heart rate recorded during the exercise period and expressed in beats per minute (bpm).

    Time frame: During each 20-minute exercise session

  8. Time Spent in the Target Heart Rate Range

    Heart rate was continuously monitored throughout each exercise condition. The outcome was the percentage of exercise time during which heart rate remained within ±5 beats/min of the individualized target heart rate corresponding to 50% heart rate reserve (HRR)

    Time frame: During each 20-minute exercise session

06

Study locations

1 site
  • Malatya Turgut Ozal University
    Malatya, Malatya 44100, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: No — Individual participant data are not planned to be shared because no data-sharing plan was established as part of the original study protocol.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07806032
Lead sponsor
Malatya Turgut Ozal University
Responsible party
Ramazan Bayer (Associate Professor, Malatya Turgut Ozal University) — Principal investigator
First posted
Sep 8, 2026
Start date
Jun 22, 2026
Primary completion
Aug 5, 2026
Completion
Aug 5, 2026
Last update
Sep 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion